As psychedelics become more visible and accessible in diverse contexts, conversation is shifting from whether they will go mainstream to how that mainstreaming unfolds, and what guardrails are needed to support safety and equity.Here, Missi Wooldridge, Heather Kuiper, Doris Payer, and Logina Mostafa argue that public health has been largely missing from this rapidly evolving landscape…

Source

Previous articlePα+ Psychedelic Bulletin #218: FDA’s Farchione Says Psychedelic INDs Are “a Third” of Her Workload; Ipsos/Psychedelic Alpha Poll; Reunion Eyes Single Phase 3 in PPD; America’s 10 Million Microdosers